IBTK

Across TCGA pan-cancer cohorts, IBTK Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated IBTK data layer compared with 27 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher IBTK Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated IBTK expression acts as an unfavorable survival marker.

LUSC, LUAD, and STAD are the cancer types where IBTK Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	II,III,IV	0.345	0.638	.005	31	view →
LUAD	OS	Median	II,III,IV	0.053	0.751	<.001	30	view →
STAD	OS	Median	All	0.184	0.730	.001	18	view →
LIHC	OS	Median	All	0.015	0.784	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

IBTK–LUSC (OS)

Open the LUSC breakdown →